180 Life Sciences Corp. (ATNF): Price and Financial Metrics
ATNF Price/Volume Stats
| Current price | $0.88 | 52-week high | $17.75 |
| Prev. close | $0.90 | 52-week low | $0.66 |
| Day low | $0.88 | Volume | 33,900 |
| Day high | $0.92 | Avg. volume | 127,118 |
| 50-day MA | $1.01 | Dividend yield | N/A |
| 200-day MA | $1.65 | Market Cap | 5.34M |
ATNF Stock Price Chart Interactive Chart >
180 Life Sciences Corp. (ATNF) Company Bio
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of drug candidates in the areas of inflammatory diseases, fibrosis, and pain. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and Anti-TNF platform, which focuses on fibrosis and anti-tumor necrosis factors; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company is headquartered in Menlo Park, California.
ATNF Price Returns
| 1-mo | -17.70% |
| 3-mo | 1.62% |
| 6-mo | -48.84% |
| 1-year | N/A |
| 3-year | -99.74% |
| 5-year | N/A |
| YTD | -51.65% |
| 2024 | -55.13% |
| 2023 | -93.70% |
| 2022 | -95.65% |
| 2021 | 42.86% |
| 2020 | N/A |
Loading social stream, please wait...